4//SEC Filing
Senderowicz Adrian 4
Accession 0001562180-19-005422
CIK 0001434418other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 5:28 PM ET
Size
15.1 KB
Accession
0001562180-19-005422
Insider Transaction Report
Form 4
Senderowicz Adrian
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-11-06$30.14/sh−10,899$328,536→ 21,335 total - Exercise/Conversion
Common Stock
2019-11-06$5.51/sh+27,232$150,048→ 43,116 total - Sale
Common Stock
2019-11-06$20.01/sh−5,431$108,662→ 37,685 total - Sale
Common Stock
2019-11-06$25.18/sh−5,451$137,256→ 32,234 total - Sale
Common Stock
2019-11-06$35.11/sh−5,451$191,394→ 15,884 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-06−27,232→ 109,020 totalExercise: $5.51Exp: 2027-07-10→ Common Stock (27,232 underlying)
Footnotes (6)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $20.00 to $20.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $25.00 to $25.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $30.00 to $30.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]This transaction was executed in multiple trades at prices ranging from $35.00 to $35.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F6]This option was granted on July 11, 2017, and has vested as to 25% of the shares underlying the option as of July 10, 2018 with the remainder vesting quarterly through July 10, 2021.
Documents
Issuer
CONSTELLATION PHARMACEUTICALS INC
CIK 0001434418
Entity typeother
Related Parties
1- filerCIK 0001616230
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 5:28 PM ET
- Size
- 15.1 KB